Cantor Fitzgerald reiterates a 'Buy' on Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS) price target raised to $8.00.
My money says this runs throw 5 tomm and hits 5.50-6 very soon. Snss is under valued
Agree...SNSS seems poised to run to $5-6 near term. I doubt it hits the Cantor $8 target, but $5-6 looks very achievable given its recent strength.